Global MagLev Ventricular Assist Device (VAD) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global MagLev Ventricular Assist Device (VAD) market size was valued at US$ 1216 million in 2024 and is forecast to a readjusted size of USD 2289 million by 2031 with a CAGR of 9.6% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which uses full magnetic levitation or magnetic-fluid hybrid levitation bearing technology.
Currently, the global magnetic levitation ventricular assist device (VAD) market is monopolized by Abbott's HeartMate 3, which has now become the most commonly used left ventricular assist device (LVAD) in the world, with a market share of over 80%.
Medtronic's HeartWare HVAD (magnetic fluid hybrid suspension ventricular assist device) is the second largest VAD device in market share after Abbott's HeartMate 3, but due to serious adverse events, the product was announced to be delisted and sales stopped in June 2021. This undoubtedly reinforces Abbott's monopoly in the VAD market.
From the perspective of the global VAD device market, the main manufacturer in the United States is Abbott, and full magnetic levitation products have become the absolute mainstream. Competition in Europe is more intense, with more products approved earlier, but they are mainly used the second-generation technology (axial pump). The main player is Berlin heart CmbH.
This report is a detailed and comprehensive analysis for global MagLev Ventricular Assist Device (VAD) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global MagLev Ventricular Assist Device (VAD) market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global MagLev Ventricular Assist Device (VAD) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global MagLev Ventricular Assist Device (VAD) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global MagLev Ventricular Assist Device (VAD) market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for MagLev Ventricular Assist Device (VAD)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global MagLev Ventricular Assist Device (VAD) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BiVACOR, Suzhou Tongxin Medical Devices, Shenzhen Core Medical Technology, RocketHeart Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
MagLev Ventricular Assist Device (VAD) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fully MagLev VAD
Hybrid Levitation VAD
Market segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others
Major players covered
Abbott
BiVACOR
Suzhou Tongxin Medical Devices
Shenzhen Core Medical Technology
RocketHeart Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe MagLev Ventricular Assist Device (VAD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of MagLev Ventricular Assist Device (VAD), with price, sales quantity, revenue, and global market share of MagLev Ventricular Assist Device (VAD) from 2020 to 2025.
Chapter 3, the MagLev Ventricular Assist Device (VAD) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the MagLev Ventricular Assist Device (VAD) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and MagLev Ventricular Assist Device (VAD) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of MagLev Ventricular Assist Device (VAD).
Chapter 14 and 15, to describe MagLev Ventricular Assist Device (VAD) sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which uses full magnetic levitation or magnetic-fluid hybrid levitation bearing technology.
Currently, the global magnetic levitation ventricular assist device (VAD) market is monopolized by Abbott's HeartMate 3, which has now become the most commonly used left ventricular assist device (LVAD) in the world, with a market share of over 80%.
Medtronic's HeartWare HVAD (magnetic fluid hybrid suspension ventricular assist device) is the second largest VAD device in market share after Abbott's HeartMate 3, but due to serious adverse events, the product was announced to be delisted and sales stopped in June 2021. This undoubtedly reinforces Abbott's monopoly in the VAD market.
From the perspective of the global VAD device market, the main manufacturer in the United States is Abbott, and full magnetic levitation products have become the absolute mainstream. Competition in Europe is more intense, with more products approved earlier, but they are mainly used the second-generation technology (axial pump). The main player is Berlin heart CmbH.
This report is a detailed and comprehensive analysis for global MagLev Ventricular Assist Device (VAD) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global MagLev Ventricular Assist Device (VAD) market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global MagLev Ventricular Assist Device (VAD) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global MagLev Ventricular Assist Device (VAD) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global MagLev Ventricular Assist Device (VAD) market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for MagLev Ventricular Assist Device (VAD)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global MagLev Ventricular Assist Device (VAD) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BiVACOR, Suzhou Tongxin Medical Devices, Shenzhen Core Medical Technology, RocketHeart Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
MagLev Ventricular Assist Device (VAD) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fully MagLev VAD
Hybrid Levitation VAD
Market segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others
Major players covered
Abbott
BiVACOR
Suzhou Tongxin Medical Devices
Shenzhen Core Medical Technology
RocketHeart Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe MagLev Ventricular Assist Device (VAD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of MagLev Ventricular Assist Device (VAD), with price, sales quantity, revenue, and global market share of MagLev Ventricular Assist Device (VAD) from 2020 to 2025.
Chapter 3, the MagLev Ventricular Assist Device (VAD) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the MagLev Ventricular Assist Device (VAD) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and MagLev Ventricular Assist Device (VAD) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of MagLev Ventricular Assist Device (VAD).
Chapter 14 and 15, to describe MagLev Ventricular Assist Device (VAD) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
82 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: MagLev Ventricular Assist Device (VAD) by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
